SILVER SPRING, Md. , Aug. 30, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) (" United Therapeutics ") today announced that it has closed the merger of SteadyMed Ltd. (NASDAQ: STDY) (" SteadyMed ") with a subsidiary of United Therapeutics .
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 8, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Watson Laboratories, Inc. ("Watson") resolving ongoing litigation concerning certain patents
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 8, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the FREEDOM-EV clinical study of Orenitram ® (treprostinil) extended-release tablets in patients suffering from
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 7, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics , will provide an overview and update on the company's business at the
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 1, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the quarter ended June 30, 2018. "Our second quarter net revenues totaled $444 million and we are treating a larger number of
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration ( FDA ) of a New Drug Application (NDA) for the use of Remodulin (treprostinil) Injection in the
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 26, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2018 financial results before the market opens on Wednesday, August 1, 2018 .
SILVER SPRING, Md. and SAN RAMON, Calif. , July 20, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) and SteadyMed Ltd. (NASDAQ: STDY) announced today the termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") relating to
SILVER SPRING, Md. and ENGLEWOOD, Colo. , June 12, 2018 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and XVIVO Perfusion, Inc. , a subsidiary of XVIVO Perfusion AB (STO: XVIVO), today announced that the use of XVIVO's ex-vivo lung perfusion (EVLP) technology will be incorporated
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 2, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2018. "Our first quarter net revenues totaled $389 million ," said Martine Rothblatt , Ph.D.,
